8,091 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Bought by Petros Family Wealth LLC

Petros Family Wealth LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 8,091 shares of the healthcare conglomerate's stock, valued at approximately $4,093,000. UnitedHealth Group makes up approximately 4.4% of Petros Family Wealth LLC's investment portfolio, making the stock its 3rd biggest holding.

A number of other institutional investors have also recently made changes to their positions in the company. NewSquare Capital LLC bought a new stake in UnitedHealth Group in the fourth quarter worth about $25,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $28,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at $30,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at $30,000. Finally, Promus Capital LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at $32,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on UNH. HSBC raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective for the company in a report on Friday, January 10th. Barclays cut their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a report on Friday, January 17th. Hsbc Global Res upgraded shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Mizuho increased their target price on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 9th. Finally, Truist Financial upped their price target on UnitedHealth Group from $610.00 to $660.00 and gave the stock a "buy" rating in a report on Friday. Twenty-one investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $632.85.

Remove Ads

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the business's stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Trading Down 2.2 %

Shares of UnitedHealth Group stock traded down $13.24 during trading hours on Monday, reaching $586.23. 4,838,165 shares of the company's stock were exchanged, compared to its average volume of 4,346,637. The firm has a market capitalization of $536.23 billion, a price-to-earnings ratio of 37.82, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a fifty day moving average of $512.87 and a 200-day moving average of $541.80. UnitedHealth Group Incorporated has a 52-week low of $438.50 and a 52-week high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group's revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter last year, the business earned $5.83 EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.43%. UnitedHealth Group's dividend payout ratio is currently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.